A common polymorphic allele of the LH beta-subunit gene is associated with higher exogenous FSH consumption during controlled ovarian stimulation for assisted reproductive technology

Reproductive Biology and Endocrinology

Volumn 11, Issue 1, 2013, Pages

  Alviggi, Carlo ^a   Pettersson, Kim ^b   Longobardi, Salvatore ^c   Andersen, Claus Yding ^d   Conforti, Alessandro ^a   De Rosa, Pasquale ^a   Clarizia, Roberto ^a   Strina, Ida ^a   Mollo, Antonio ^a   De Placido, Giuseppe ^a   Humaidan, Peter ^e  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b UNIVERSITY OF TURKU   (Finland)

^c Merck Serono   (Italy)

^d Mental Health Services CPH   (Denmark)

^e ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Beta subunit variant; Immunoassays; IVF; LH; Pharmacogenomics; Polymorphism; Poor responders

Indexed keywords

ESTRADIOL; FOLLITROPIN; GONADORELIN AGONIST; LUTEINIZING HORMONE; LUTEINIZING HORMONE BETA SUBUNIT; RECOMBINANT FOLLITROPIN; ESTROGEN; GONADORELIN;

ADULT; ARTICLE; BLOOD SAMPLING; BODY MASS; CONTROLLED OVARIAN STIMULATION; DENMARK; DNA POLYMORPHISM; DRUG MEGADOSE; FEMALE; FERTILIZATION; FLUOROMETER; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; INFERTILITY THERAPY; MAJOR CLINICAL STUDY; OBSTETRIC PROCEDURE; OOCYTE RETRIEVAL; OUTCOME ASSESSMENT; POPULATION; PREGNANCY RATE; RECEPTOR DOWN REGULATION; RETROSPECTIVE STUDY; TREATMENT OUTCOME; AGONISTS; ALLELE; EPIDEMIOLOGY; GENETIC POLYMORPHISM; GENETICS; INFERTILITY, FEMALE; OVULATION INDUCTION; PROCEDURES;

ADULT; ALLELES; DENMARK; ESTROGENS; FEMALE; FOLLICLE STIMULATING HORMONE; GENE FREQUENCY; GONADOTROPIN-RELEASING HORMONE; HUMANS; INFERTILITY, FEMALE; LUTEINIZING HORMONE, BETA SUBUNIT; OVULATION INDUCTION; POLYMORPHISM, GENETIC; REPRODUCTIVE TECHNIQUES, ASSISTED; RETROSPECTIVE STUDIES;

EID: 84878376382     PISSN: None     EISSN: 14777827     Source Type: Journal    
DOI: 10.1186/1477-7827-11-51     Document Type: Article

References (27)

1. De Placido G, Mollo A, Alviggi C, Strina I, Varricchio MT, Ranieri A, Colacurci N, Tolino A, Wilding M. Rescue of in vitro fertilisation cycles by human menopausal gonadotropin in pituitary down-regulated normogonadotrophic young women characterised by a poor initial response to recombinant follicle stimulating hormone. Hum Reprod 2001, 16:1875-1879. 10.1093/humrep/16.9.1875, 11527891.
2. De Placido G, Alviggi C, Mollo A, Strina I, Ranieri A, Alviggi E, Wilding M, Varricchio MT, Borrelli AL, Conforti S. Effects of recombinant LH (rLH) supplementation during controlled ovarian hyperstimulation (COH) in normogonadotrophic women with an initial inadequate response to recombinant FSH (rFSH) after pituitary down regulation. Clin Endocrinol 2004, 60:637-643.
3. Ferraretti AP, Gianaroli L, Magli MC, D'angelo A, Farfalli V, Montanaro N. Exogenous luteinizing hormone in controlled ovarian hyperstimulation for assisted reproduction techniques. Fertil Steril 2004, 82:1521-1526. 10.1016/j.fertnstert.2004.06.041, 15589853.
4. De Placido G, Alviggi C, Perino A, Strina I, Lisi F, Fasolino A, De Palo R, Ranieri A, Colacurci N, Mollo A. on behalf of the Italian Collaborative Group on Recombinant Human Luteinizing Hormone Recombinant human LH supplementation versus recombinant human FSH (r-hFSH) step-up protocol during controlled ovarian stimulation in normogonadotrophic women with initial inadequate ovarian response to r-hFSH. A multicentre, prospective, randomized controlled trial. Hum Reprod 2005, 20:390-396. on behalf of the Italian Collaborative Group on Recombinant Human Luteinizing Hormone.
5. Mochtar MH, van der Veen F, Ziech M, van Wely M. Recombinant luteinizing hormone (rLH) for controlled ovarian hyperstimulation in assisted reproductive cycles. Cochrane Database Syst Rev 2007, 18:CD005070.
6. Alviggi C, Clarizia R, Mollo A, Ranieri A, De Placido G. Who needs LH in ovarian stimulation?. Reprod Biomed Online 2006, 12:599-607. 10.1016/S1472-6483(10)61186-8, 16790105.
7. Alviggi C, Clarizia R, Pettersson K, Mollo A, Humaidan P, Strina I, Coppola M, Ranieri A, D'Uva M, De Placido G. Suboptimal response to GnRH-a long protocol is associated with a common LH polymorphism. Reprod Biomed Online 2009, 18:9-14. 10.1016/S1472-6483(10)60418-X, 19146763.
8. Jeppesen JV, Kristensen SG, Nielsen ME, Humaidan P, Dal Canto M, Fadini R, Schmidt KT, Ernst E, Yding Andersen C. LH-Receptor Gene Expression in Human Granulosa and Cumulus Cells from Antral and Preovulatory Follicles. J Clin Endocrinol Metab 2012, 97:1524-1531.
9. Weiss J, Axelrod L, Whitcomb RW, Harris PE, Crowley WF, Jameson JL. Hypogonadism caused by a single amino acid substitution in the beta subunit of luteinizing hormone. N Engl J Med 1992, 326:179-183. 10.1056/NEJM199201163260306, 1727547.
10. Pettersson K, Ding YQ, Huhtaniemi I. An immunologically anomalous luteinizing hormone variant in a healthy woman. J Clin Endocrinolol Metab 1992, 74:164-171.
11. Suganuma N, Furui K, Kikkawa F, Tomoda Y, Furuhashi M. Effects of the mutations Trp8™Arg and Ile15™Thr. in human luteinizing hormone LH.beta-subunit on LH bioactivity in vitro and in vivo. Endocrinology 1996, 137:831-838. 10.1210/en.137.3.831, 8603592.
12. Haavisto AM, Pettersson K, Bergendahl M, Virkamäki A, Huhtaniemi I. Occurrence and biological properties of a common genetic variant of luteinizing hormone. J Clin Endocrinol Metab 1995, 80:1257-1263. 10.1210/jc.80.4.1257, 7714098.
13. Humaidan P, Bungum L, Bungum M, Andersen CY. Ovarian response and pregnancy outcome related to mid-follicular LH concentrations in women undergoing assisted reproduction with GnRH agonist down regulation and recombinant FSH stimulation. Hum Reprod 2002, 17:2016-2021. 10.1093/humrep/17.8.2016, 12151430.
14. Pettersson K, Söderholm JR. Ultrasensitive two-site immunometric assay of human lutropin by time-resolved fluorometry. Clin Chem 1990, 36:1928-1933.
15. Pettersson K, Söderholm JR. Individual differences in lutropin immunoreactivity revealed by monoclonal antibodies. Clin Chem 1991, 37:333-340.
16. Nilsson C, Jiang M, Pettersson K, Iitiä A, Mäkelä M, Simonsen H, Easteal S, Herrera RJ, Huhtaniemi I. Determination of a common genetic variant of luteinizing hormone using DNA hybridization and immunoassays. Clin Endocrinol (Oxf) 1998, 49:369-376.
17. Nilsson C, Pettersson K, Millar RP, Coerver KA, Matzuk MM, Huhtaniemi IT. Worldwide frequency of a common genetic variant of luteinizing hormone: an international collaborative research. International Collaborative Research Group. Fertil Steril 1997, 67:998-1004. 10.1016/S0015-0282(97)81430-6, 9176435.
18. Huhtaniemi I, Jiang M, Nilsson C, Pettersson K. Mutations and polymorphisms in gonadotropin genes. Mol Cel Endocrinol 1999, 151:89-94.
19. Rajkhowa M, Talbot JA, Jones PW, Pettersson K, Haavisto AM, Huhtaniemi I, Clayton RN. Prevalence of an immunological LH beta-subunit variant in a UK population of healthy women and women with polycystic ovary syndrome. Clin Endocrinol (Oxf) 1995, 43:297-303.
20. Tapanainen JS, Koivunen R, Fauser BC, Taylor AE, Clayton RN, Rajkowa M, White D, Franks S, Anttila L, Pettersson KS, Huhtaniemi I. A new contributing factor to polycystic ovary syndrome: the genetic variant of luteinizing hormone. J Clin Endocrinol Metab 1999, 84:1711-1715. 10.1210/jc.84.5.1711, 10323405.
21. Takahashi K, Kurioka H, Ozaki T, Kanasaki H, Kohsaka M, Miyazaki K, Karino K. Increased prevalence of luteinizing hormone beta-subunit variant in Japanese infertility patients. Hum Reprod 1998, 13:3338-3344. 10.1093/humrep/13.12.3338, 9886510.
22. Takahashi K, Karino K, Kanasaki H, Miyazaki K. Altereted kinetics of pituitary response to gonadotropin-release hormone in woman with variant luteinizing hormone: correlation with ovulatory disorders. Horm Res 2004, 61:27-32. 10.1159/000075194, 14646399.
23. Chen X, Zhou B, Yan J, Xu B, Tai P, Li J, Peng S, Zhang M, Xia G. Epidermal growth factor receptor activation by protein kinase C is necessary for FSH-induced meiotic resumption in porcine cumulus-oocyte complexes. J Endocrinol 2008, 197:409-419. 10.1677/JOE-07-0592, 18434371.
24. Wang C, Xu B, Zhou B, Zhang C, Yang J, Ouyang H, Ning G, Zhang M, Shen J, Xia G. Reducing CYP51 inhibits follicle-stimulating hormone induced resumption of mouse oocyte meiosis in vitro. J Lipid Res 2009, 50:2164-2172. 10.1194/jlr.M800533-JLR200, 2759822, 19433477.
25. Yang J, Fu M, Wang S, Chen X, Ning G, Xu B, Ma Y, Zhang M, Xia G. An Antisense Oligodeoxynucleotide to the LH Receptor Attenuates FSH-induced Oocyte Maturation in Mice. Asian-Aust J Anim Sci 2008, 21:972-979.
26. Humaidan P, Bungum M, Bungum L, Yding Andersen C. Effects of recombinant LH supplementation in women undergoing assisted reproduction with GnRH agonist down-regulation and stimulation with recombinant FSH: an opening study. Reprod Biomed Online 2004, 8:635-643. 10.1016/S1472-6483(10)61643-4, 15169576.
27. Smyth CD, Miró F, Whitelaw PF, Howles CM, Hillier SG. Ovarian thecal/interstitial androgen synthesis is enhanced by a follicle-stimulating hormone-stimulated paracrine mechanism. Endocrinology 1993, 133:1532-1538. 10.1210/en.133.4.1532, 8404591.